1. Gianfrancesco, Olympia, Bubb, Vivien J, Quinn, John P. 2016. SVA retrotransposons as potential modulators of neuropeptide gene expression. In Neuropeptides, 64, 3-7. doi:10.1016/j.npep.2016.09.006. https://pubmed.ncbi.nlm.nih.gov/27743609/
2. Leek, Jeffrey T, Johnson, W Evan, Parker, Hilary S, Jaffe, Andrew E, Storey, John D. 2012. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. In Bioinformatics (Oxford, England), 28, 882-3. doi:10.1093/bioinformatics/bts034. https://pubmed.ncbi.nlm.nih.gov/22257669/
3. Nicoletto, Giulia, Terreri, Marianna, Maurizio, Ilaria, Schotta, Gunnar, Richter, Sara N. . G-quadruplexes in an SVA retrotransposon cause aberrant TAF1 gene expression in X-linked dystonia parkinsonism. In Nucleic acids research, 52, 11571-11586. doi:10.1093/nar/gkae797. https://pubmed.ncbi.nlm.nih.gov/39287133/
4. Fröhlich, Alexander, Hughes, Lauren S, Middlehurst, Ben, Koks, Sulev, Quinn, John P. 2023. CRISPR deletion of a SINE-VNTR-Alu (SVA_67) retrotransposon demonstrates its ability to differentially modulate gene expression at the MAPT locus. In Frontiers in neurology, 14, 1273036. doi:10.3389/fneur.2023.1273036. https://pubmed.ncbi.nlm.nih.gov/37840928/
5. Yu, Hanwen, Chen, Manqi, Hu, Yuanlang, Wang, Wenjun, Wang, Jichang. . Dynamic reprogramming of H3K9me3 at hominoid-specific retrotransposons during human preimplantation development. In Cell stem cell, 29, 1031-1050.e12. doi:10.1016/j.stem.2022.06.006. https://pubmed.ncbi.nlm.nih.gov/35803225/